Cargando…

Differences in receipt of multimodality therapy by race, insurance status, and socioeconomic disadvantage in patients with resected pancreatic cancer

BACKGROUND AND METHODS: Racial and socioeconomic disparities in receipt of adjuvant chemotherapy affect patients with pancreatic cancer. However, differences in receipt of neoadjuvant chemotherapy among patients undergoing resection are not well‐understood. A retrospective cross‐sectional cohort of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hao, Scarlett, Mitsakos, Anastasios, Irish, William, Tuttle‐Newhall, Janet Elizabeth, Parikh, Alexander A., Snyder, Rebecca A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Pancreas
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9545601/ https://www.ncbi.nlm.nih.gov/pubmed/35315932 http://dx.doi.org/10.1002/jso.26859

Ejemplares similares

The association of health insurance and race with treatment and survival in patients with metastatic colorectal cancer
por: Mitsakos, Anastasios T., et al.
Publicado: (2022)

The impact of race/ethnicity on pancreaticoduodenectomy outcomes for pancreatic cancer
por: Alwatari, Yahya, et al.
Publicado: (2022)

Validating biologic age in selecting elderly patients with pancreatic cancer for surgical resection
por: Scholer, Anthony J., et al.
Publicado: (2022)

Targeting mTOR dependency in pancreatic cancer
por: Morran, Douglas C, et al.
Publicado: (2014)

Association of race and health insurance in treatment disparities of colon cancer: A retrospective analysis utilizing a national population database in the United States
por: Hao, Scarlett, et al.
Publicado: (2021)

Correction: Association of race and health insurance in treatment disparities of colon cancer: A retrospective analysis utilizing a national population database in the United States
por: Hao, Scarlett, et al.
Publicado: (2022)

Prediction of infected pancreatic necrosis in acute necrotizing pancreatitis by the modified pancreatitis activity scoring system
por: Mao, Wenjian, et al.
Publicado: (2022)

Metabolic biomarker signature to differentiate pancreatic ductal adenocarcinoma from chronic pancreatitis
por: Mayerle, Julia, et al.
Publicado: (2018)

Post‐pancreatitis diabetes mellitus is common in chronic pancreatitis and is associated with adverse outcomes
por: Dugic, Ana, et al.
Publicado: (2022)

Efficacy of pancreatic enzyme replacement therapy in chronic pancreatitis: systematic review and meta-analysis
por: de la Iglesia-García, Daniel, et al.
Publicado: (2017)

Relationship between pancreatic parenchyma loss and early postoperative hyperglycemia in patients with benign pancreatic diseases
por: Wen, Kan, et al.
Publicado: (2021)

Pancreatic enzyme treatment in chronic pancreatitis: Quality of management and adherence to guidelines–A cross‐sectional observational study
por: Erchinger, Friedemann, et al.
Publicado: (2022)

Reversal of pancreatic desmoplasia by a tumour stroma-targeted nitric oxide nanogel overcomes TRAIL resistance in pancreatic tumours
por: Huang, Hsi-Chien, et al.
Publicado: (2022)

UEG position paper on pancreatic cancer. Bringing pancreatic cancer to the 21st century: Prevent, detect, and treat the disease earlier and better
por: Michl, Patrick, et al.
Publicado: (2021)

The microbiome in pancreatic diseases: Recent advances and future perspectives
por: Ammer-Herrmenau, Christoph, et al.
Publicado: (2020)

Complementary role of computed tomography texture analysis for differentiation of pancreatic ductal adenocarcinoma from pancreatic neuroendocrine tumors in the portal-venous enhancement phase
por: Reinert, Christian Philipp, et al.
Publicado: (2020)

SUMO pathway inhibition targets an aggressive pancreatic cancer subtype
por: Biederstädt, Alexander, et al.
Publicado: (2020)

Structural imaging findings are related to clinical complications in chronic pancreatitis
por: Nordaas, Ingrid Kvåle, et al.
Publicado: (2022)

A faecal microbiota signature with high specificity for pancreatic cancer
por: Kartal, Ece, et al.
Publicado: (2022)

Consensus definition of sludge and microlithiasis as a possible cause of pancreatitis
por: Żorniak, Michal, et al.
Publicado: (2023)

Digital next-generation sequencing identifies low-abundance mutations in pancreatic juice samples collected from the duodenum of patients with pancreatic cancer and intraductal papillary mucinous neoplasms
por: Yu, Jun, et al.
Publicado: (2017)

Long-term outcomes of autoimmune pancreatitis: a multicentre, international analysis
por: Hart, Phil A, et al.
Publicado: (2013)

Switchable CAR-T cells mediate remission in metastatic pancreatic ductal adenocarcinoma
por: Raj, Deepak, et al.
Publicado: (2019)

Enrichment of oral microbiota in early cystic precursors to invasive pancreatic cancer
por: Gaiser, Rogier Aäron, et al.
Publicado: (2019)

Long-term yield of pancreatic cancer surveillance in high-risk individuals
por: Overbeek, Kasper A, et al.
Publicado: (2022)

Molecular heterogeneity and commonalities in pancreatic cancer precursors with gastric and intestinal phenotype
por: Liffers, Sven-Thorsten, et al.
Publicado: (2023)

Quantitative MRI of chronic pancreatitis: results from a multi-institutional prospective study, magnetic resonance imaging as a non-invasive method for assessment of pancreatic fibrosis (MINIMAP)
por: Tirkes, Temel, et al.
Publicado: (2022)

Time to progression of pancreatic ductal adenocarcinoma from low-to-high tumour stages
por: Yu, Jun, et al.
Publicado: (2015)

SWI/SNF component ARID1A restrains pancreatic neoplasia formation
por: Wang, Sam C, et al.
Publicado: (2019)

Serum phosphate is associated with mortality among patients admitted to ICU for acute pancreatitis
por: Hedjoudje, Abdellah, et al.
Publicado: (2021)

Activity of acute pancreatitis is modified by secreted protein acidic and rich in cysteine ablation
por: Ammer‐Herrmenau, Christoph, et al.
Publicado: (2022)

Cost–effectiveness of pancreatic cancer screening: Time for a more tailored approach
por: Archibugi, Livia, et al.
Publicado: (2023)

Quality of life after endoscopic procedures for chronic pancreatitis: A multicentre study
por: Parhiala, Mikael, et al.
Publicado: (2023)

Pancreatic cancer cell lines as patient-derived avatars: genetic characterisation and functional utility
por: Knudsen, Erik S, et al.
Publicado: (2018)

Stromal protein βig-h3 reprogrammes tumour microenvironment in pancreatic cancer
por: Goehrig, Delphine, et al.
Publicado: (2019)

Synergistic targeting and resistance to PARP inhibition in DNA damage repair-deficient pancreatic cancer
por: Gout, Johann, et al.
Publicado: (2021)

The additive value of CA19.9 monitoring in a pancreatic cyst surveillance program
por: Levink, Iris J. M., et al.
Publicado: (2023)

Lysosomal lipid switch sensitises to nutrient deprivation and mTOR targeting in pancreatic cancer
por: De Santis, Maria Chiara, et al.
Publicado: (2023)

Impact of Tumor Grade on Prognosis in Pancreatic Cancer: Should We Include Grade in AJCC Staging?
por: Wasif, Nabil, et al.
Publicado: (2010)

Comprehensive characterisation of pancreatic ductal adenocarcinoma with microsatellite instability: histology, molecular pathology and clinical implications
por: Luchini, Claudio, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_oaa96io5utu2jbpto309903qoa